Accelerating scale up and commercialisation of 100% bacteria free eggs for use in production of vaccines

Project Information

Ovavax2

Grant agreement ID: 190136873

DOI 10.3030/190136873

Project closed

EC signature date 26 October 2022

Start date 1 November 2022

End date 31 October 2024

Funded under

• The European Innovation Council (EIC)

Total cost € 3 571 428,75

EU contribution € 2 500 000,00

Coordinated by

OVAGEN GROUP LIMITED
Ireland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Submission of articles to minimum of 2 journals

Websites, patent fillings, videos etc. (2)

Exhibition at minimum 2 international conferences confirmed
Marketing collateral developed

Publications

Peer reviewed articles (2)

Microbiological Assessment and Evaluation of Virus Yield in Germ-free Chicken Eggs

Author(s): Oluwapelumi Adeyemi, Ariane G B dos Santos, Jean-Rémy Sadeyen, Toby Carter, Martin Murphy, Catherine Caulfield, Leonard Moran, Modupeore Adeyemi, Munir Iqbal
Published in: The Open Microbiology Journal, Issue 18, 2024, ISSN 1874-2858
Publisher: Bentham Science Publishers Ltd.
DOI: 10.2174/0118742858343360241114112015

A Novel Method to Sterilize Isolators for the Housing of Germ-Free Birds and Production of Germ-Free Eggs

Author(s): Martin Murphy, Rhys Jones, Ariane dos Santos, Modupeore Adeyemi, and Catherine Caulfield
Published in: Applied Biosafety, 2024, ISSN 1535-6760
Publisher: ABSA International
DOI: 10.1089/apb.2024.0007